Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Army
Express Scripts
US Department of Justice
Mallinckrodt
Colorcon
UBS
Queensland Health
Argus Health
Citi

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,312,924

« Back to Dashboard

Summary for Patent: 5,312,924
Title: Phenylacetic acid benzylamides
Abstract:The present application relates to the uses of phenylacetic acid benzylamides and new (S)(+)-2-ethoxy-4-[N-[1-2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbon ylmethyl]benzoic acid and the salts thereof, which have valuable pharmacological properties, namely an effect on the intermediate metabolism, but particularly the effect of lowering blood sugar.
Inventor(s): Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss, deceased; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Ruprecht; Eckhard (Aulendorf-Tannhausen, DE)
Assignee: Dr. Karl Thomae GmbH (Biberach an der Riss, DE)
Application Number:07/919,820
Patent Claim Types:
see list of patent claims
Use; Compound;

Drugs Protected by US Patent 5,312,924

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,312,924

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 44027 ➤ Try a Free Trial
Austria 52255 ➤ Try a Free Trial
Austria 53028 ➤ Try a Free Trial
Australia 3721084 ➤ Try a Free Trial
Australia 577815 ➤ Try a Free Trial
Australia 583631 ➤ Try a Free Trial
Australia 587263 ➤ Try a Free Trial
Australia 5913986 ➤ Try a Free Trial
Australia 5938386 ➤ Try a Free Trial
Bulgaria 61519 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
Colorcon
Merck
UBS
Johnson and Johnson
Julphar
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot